Wang Z, Jiang C, He Q, Matsuda M, Han Q, Wang K, et al. Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. Sci Transl Med. 2020;12: pubmed publisher

Kuo A, Magiera J, Rethwan N, Andersson A, Leen Lam A, Wyse B, et al. In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile. Eur J Pharmacol. 2020;872:172947 pubmed publisher

Birdsong W, Jongbloets B, Engeln K, Wang D, Scherrer G, Mao T. Synapse-specific opioid modulation of thalamo-cortico-striatal circuits. elife. 2019;8: pubmed publisher

Patton M, Padgett K, McKeon P, Lu S, Abrams T, Mathur B. An Aplysia-like synaptic switch for rapid protection against ethanol-induced synaptic inhibition in a mammalian habit circuit. Neuropharmacology. 2019;144:1-8 pubmed publisher

Wang Y, Chai J, Xu X, Ye R, Zan G, Liu G, et al. Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist. Sci Rep. 2018;8:14087 pubmed publisher

Thompson A, Feeney C, Kristal M. Amniotic-fluid ingestion enhances central δ-opioid-induced hypoalgesia in rats in the cold-water tail-flick assay in a repeated-measures design. Brain Res. 2018;1697:53-58 pubmed publisher

Dunn A, Reed B, Guariglia C, Dunn A, Hillman J, Kreek M. Structurally Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice. Int J Neuropsychopharmacol. 2018;21:847-857 pubmed publisher

Jacobs B, Pando M, Jennings E, Chavera T, Clarke W, Berg K. Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy. Mol Pharmacol. 2018;93:376-386 pubmed publisher

Perkovska S, Mejean C, Ayoub M, Li J, Hemery F, Corbani M, et al. V1b vasopressin receptor trafficking and signaling : role of arrestins, G proteins and Src kinase. Traffic. 2017;: pubmed publisher

Asahi H, Inoue S, Niikura M, Kunigo K, Suzuki Y, Kobayashi F, et al. Profiling molecular factors associated with pyknosis and developmental arrest induced by an opioid receptor antagonist and dihydroartemisinin in Plasmodium falciparum. PLoS ONE. 2017;12:e0184874 pubmed publisher

Bull F, Baptista Hon D, Lambert J, Walwyn W, Hales T. Morphine activation of mu opioid receptors causes disinhibition of neurons in the ventral tegmental area mediated by β-arrestin2 and c-Src. Sci Rep. 2017;7:9969 pubmed publisher

Zádor F, Király K, Váradi A, Balogh M, Fehér Ã, Kocsis D, et al. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology. Eur J Pharmacol. 2017;809:111-121 pubmed publisher

Panahi Y, Saboory E, Rassouli A, Sadeghi Hashjin G, Roshan Milani S, Derafshpour L, et al. The effect of selective opioid receptor agonists and antagonists on epileptiform activity in morphine-dependent infant mice hippocampal slices. Int J Dev Neurosci. 2017;60:56-62 pubmed publisher

Floettmann E, Bui K, Sostek M, Payza K, Eldon M. Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation. J Pharmacol Exp Ther. 2017;361:280-291 pubmed publisher

Cerlesi M, Ding H, Bird M, Kiguchi N, Ferrari F, Malfacini D, et al. Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13). Eur J Pharmacol. 2017;794:115-126 pubmed publisher

Robertson D, Sleno R, Nagi K, Pétrin D, Hébert T, Pineyro G. Design and construction of conformational biosensors to monitor ion channel activation: A prototype FlAsH/BRET-approach to Kir3 channels. Methods. 2016;92:19-35 pubmed publisher

Gadetskaya A, Taráwneh A, Zhusupova G, Gemejiyeva N, Cantrell C, Cutler S, et al. Sulfated phenolic compounds from Limonium caspium: Isolation, structural elucidation, and biological evaluation. Fitoterapia. 2015;104:80-5 pubmed publisher

Bird M, Vardanyan R, Hruby V, Calo G, Guerrini R, Salvadori S, et al. Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands. Br J Anaesth. 2015;114:646-56 pubmed publisher

Chajra H, Amstutz B, Schweikert K, Auriol D, Redziniak G, Lefèvre F. Opioid receptor delta as a global modulator of skin differentiation and barrier function repair. Int J Cosmet Sci. 2015;37:386-94 pubmed publisher

Zádor F, Lénárt N, Csibrány B, Sántha M, Molnár M, Tuka B, et al. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner. Neuropharmacology. 2015;89:298-307 pubmed

Mika J, Popiolek Barczyk K, Rojewska E, Makuch W, Starowicz K, Przewlocka B. Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain. PLoS ONE. 2014;9:e104420 pubmed publisher

Gassaway M, Rives M, Kruegel A, Javitch J, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Transl Psychiatry. 2014;4:e411 pubmed publisher

Kuo A, Wyse B, Meutermans W, Smith M. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile. Br J Pharmacol. 2015;172:532-48 pubmed publisher

Andersen S, Baar C, Fladvad T, Laugsand E, Skorpen F. The N-terminally truncated µ3 and µ3-like opioid receptors are transcribed from a novel promoter upstream of exon 2 in the human OPRM1 gene. PLoS ONE. 2013;8:e71024 pubmed publisher

Nockemann D, Rouault M, Labuz D, Hublitz P, McKnelly K, Reis F, et al. The K(+) channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia. EMBO Mol Med. 2013;5:1263-77 pubmed publisher

Morse M, Sun H, Tran E, Levenson R, Fang Y. Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family. BMC Pharmacol Toxicol. 2013;14:17 pubmed publisher

Charbaji N, Schäfer Korting M, Küchler S. Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation. PLoS ONE. 2012;7:e42616 pubmed publisher

Morse M, Tran E, Sun H, Levenson R, Fang Y. Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target. PLoS ONE. 2011;6:e25643 pubmed publisher

Cheng Y, Tao Y, Sun J, Wang Y, Xu X, Chen J, et al. Adenosine A(1) receptor agonist N(6)-cyclohexyl-adenosine induced phosphorylation of delta opioid receptor and desensitization of its signaling. Acta Pharmacol Sin. 2010;31:784-90 pubmed publisher

Archer Lahlou E, Audet N, Amraei M, Huard K, Paquin Gobeil M, Pineyro G. Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling. J Cell Mol Med. 2009;13:147-63 pubmed publisher

Parenty G, Appelbe S, Milligan G. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer. Biochem J. 2008;412:245-56 pubmed publisher

Ankö M, Panula P. Functional modulation of human delta opioid receptor by neuropeptide FF. BMC Neurosci. 2005;6:21 pubmed

Gharagozlou P, Demirci H, Clark J, Lameh J. Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors. BMC Neurosci. 2002;3:19 pubmed

Witt K, Huber J, Egleton R, Roberts M, Bentley M, Guo L, et al. Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2, D-Pen5]-enkephalin (DPDPE). J Pharmacol Exp Ther. 2001;298:848-56 pubmed

Gao B, Hagenbuch B, Kullak Ublick G, Benke D, Aguzzi A, Meier P. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther. 2000;294:73-9 pubmed

Piros E, Charles R, Song L, Evans C, Hales T. Cloned delta-opioid receptors in GH(3) cells inhibit spontaneous Ca(2+) oscillations and prolactin release through K(IR) channel activation. J Neurophysiol. 2000;83:2691-8 pubmed

Allouche S, Hasbi A, Ferey V, Sola B, Jauzac P, Polastron J. Pharmacological delta1- and delta2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities. Biochem Pharmacol. 2000;59:915-25 pubmed

Jewett D, Mosberg H, Woods J. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons. Psychopharmacology (Berl). 1996;127:225-30 pubmed

Devine D, Wise R. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci. 1994;14:1978-84 pubmed

Akiyama K, Gee K, Mosberg H, Hruby V, Yamamura H. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15). Proc Natl Acad Sci U S A. 1985;82:2543-7 pubmed

Portoghese P, Sultana M, Takemori A. Naltrindole 5'-isothiocyanate: a nonequilibrium, highly selective delta opioid receptor antagonist. J Med Chem. 1990;33:1547-8 pubmed